Stock Updates

How has Incyte Corporation:(NASDAQ:INCY) performed recently?

Incyte Corporation (NASDAQ: INCY) is a large market cap stock with a market cap of 16650.02. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 421.56, a forward P/E of 65.07 and EPS of 0.21. At a stock price of 90.28 (1.50%) it has a dividend yield of *TBA.

EPS growth for the last five years have been 16.40%, more recently this last year it has grown by 112.10%. The next year growth is going to be about 2689.80% and more long-term 38.70% after five years. EPS growth quarter over quarter is 217.00%. Sales growth for the past five years have been 34.70% and sales growth quarter over quarter is 65.40%.

For performance, Incyte Corporation the past week has seen a gain of 2.29%. For the last month performance for Incyte Corporation is 9.45%. While the last quarter is 23.39% and half year, 29.03%. Finally for the year, performance is -14.45%.

The 52-week high for Incyte Corporation, is at -32.44%, and for the 52-week low it comes to a value of 64.15%. The 20-day simple moving average is 8.97% and 4.31% for the 200-day simple moving average.

Volatility for the week is at 3.39%, and for the month it is 3.11%. Incyte Corporation, has a target price of 93.07.

In terms of debt, long term debt/equity is 2.76, and for total debt/equity Incyte Corporation has 0. The gross margin is 96.50%, while operating margin is 10.90%, the profit margin is 5.70%. The current ratio is 4.7 and the quick ratio is 4.7.

Insider ownership is at 0.50%, with instituitional ownership at 99.30%. Incyte Corporation has a payout ratio of 0.00%. With the total shares outstanding coming to 187.18. The shares float is 186.54, with the float short at 2.42%, with short ratio coming to 4.17.

In terms of returns, the return on assets see Incyte Corporation, get 4.90%, with its returns on investment at 6.30%. Return on equity is 36.10%. So will the investors see the target price of 93.07, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Tony Dabbs

Leave a Comment